The medical landscape is undergoing a seismic shift with the rise of GLP-1 (glucagon-like peptide-1) diabetes and weight-loss treatments. Novo Nordisk’s Ozempic and Wegovy, along with Eli Lilly’s Mounjaro, have been at the forefront of this revolution. These treatments, originally developed for managing type-2 diabetes, have shown remarkable efficacy in…
Tag: LLY
My Stock Watchlist: A Long-Term Perspective
As a long-term investor, I focus on identifying companies with strong fundamentals, competitive advantages, and growth potential that make them ideal candidates for holding over an extended period. The stocks listed below are just a few of the companies that have caught my eye, but they are by no means…